In response to the needs of medical tests, AMPER is committed to building the world's leading platform for the development and production of high-quality in-vitro diagnostic reagents and cooperating with global medical application institutions to open a new era of medical in-vitro diagnostics.

In February 2020, AMPER, merged Metammune LLC, and now has a professional team of more than 30 employees, 99% of whom have higher education. The team has rich experience in IVD R&D and industrialization. AMPER has established industrial bases with advanced facilities in Shenzhen, Jiangxi, Shandong, and Anhui, developing a few core technology platforms, including colloidal gold platform, fluorescence immunochromatography platform, nucleic acid detection platform and mass spectrometry technology platform. AMPER continues to provide "the best quality, the fastest test, the lowest cost" products. AMPER has established friendly business relations with dozens of medical institutions around the world.

"Innovation, pursuit and progress", AMPER is looking forward to working with partners to build an ecosystem and healthy society with people's health needs.

Copyright 2021, AMPER, INC, All rights reserved. Su ICP bei 20001328 No.